论文部分内容阅读
Aims-Fluoroscopy is not available in every endoscopic unit. This situation leads to delays in treatment or to transfer of patients to other centres for stent insertion. We assessed safety and effectiveness of expandable esophageal metal stent placement under endoscopic control without fluoroscopy using a thin gastroscope. Patients and methods - From October 2002 to June 2004, thirty- three consecutive patients have been included for esophageal stent placement under endoscopic control alone with a nasogastroscope (5.9 mm). A proximal release covered stent (Ultraflex; Boston Scientific Microvasive) was used. Indications were malignant esophageal stricture (N = 26), malignant extrinsic compression (N = 2 ) and esophago- respiratory neoplastic fistulae (N = 5). Results - Stent placement using endoscopic control alone was successful in 30/33 (90% ) patients. Complications occurred in 11 patients. Early complications (< 7 days) included one death from pulmonary embolism, severe retrosternal pain needing transient morphinic treatment (N = 2) and GERD despite antisecretory therapy (N = 1). Late complications included: food impaction (N = 1), tumour overgrowth- related obstruction of the stent (N = 5) and one late esophago- respiratory fistula at 4 months at the proximal end of the stent. Relief of dysphagia was obtained for all patients at 48 hours and dysphagia score decreased from 3.1 before stent to 1.2 at 1 month (P < 0.05). Conclusion - Expandable esophageal stents can be accurately and safely placed using endoscopy with a thin gastrosocope. This method obviates the requirement of fluoroscopic access, lacking in many centres, and avoids exposure to X- ray.
This situation leads to delays in treatment or to transfer of patients to other centers for stent insertion. We assessed safety and effectiveness of expandable esophageal metal stent placement under endoscopic control without fluoroscopy using a thin gastroscope Patients and methods - From October 2002 to June 2004, thirty-three consecutive patients have been included for esophageal stent placement under endoscopic control alone with a nasogastroscope (5.9 mm). A proximal release covered stent (Ultraflex; Boston Scientific Microvasive) was used . Results - Stent placement using endoscopic control alone was successful in 30/33 (90%). Indications were malignant esophageal stricture (N = 26), malignant extrinsic compression (N = 2) and esophago-respiratory neoplastic fistulae patients. Complications occurred in 11 patients. Early complications (<7 days) included one death from pulmonary embolism, severe retrosternal pain needing transient morphinic treatment (N = 2) and GERD despite antisecretory therapy (N = 1). Late complications included: food impaction (N = 1), tumor overgrowth- related obstruction of the stent - respiratory fistula at 4 months at the proximal end of the stent. Relief of dysphagia was obtained for all patients for 48 hours and dysphagia score decreased from 3.1 before stent to 1.2 at 1 month (P <0.05). Conclusion - Expandable esophageal stents can be well and safely placed using endoscopy with a thin gastrosocope. This method obviates the requirement of fluoroscopic access, lacking in many centers, and avoids exposure to X- ray.